The NHS Diabetes Prevention Programme: an observational study of service delivery and patient experience
BMC Health Services Research volume 20, Article number: 1098 (2020)
The NHS Diabetes Prevention Programme (NHS-DPP) is a nine-month, group-based behavioural intervention for adults in England at risk of developing Type 2 diabetes. Four independent providers were commissioned to deliver versions of the NHS-DPP, in line with NHS England specifications. This observational study maps NHS-DPP delivery in routine practice against the NHS specification, and compares service delivery with observed patient experiences.
Researchers observed service delivery across eight complete NHS-DPP courses (118 sessions, median 14 sessions per course), consenting 455 participants (36 staff, 398 patients, 21 accompanying persons). Key features of NHS-DPP delivery were described using the Template for Intervention Description and Replication (TIDieR) framework. Researchers wrote detailed field notes during each session, including observations of patient experience. Field notes were content analysed; instances of positive and negative experiences were labelled and grouped into categories. Researchers used a novel method of comparing observed patient experiences to variations in programme delivery.
Delivery broadly followed NHS England’s specification and the plans set out by providers. Deviations included the scheduling and larger group sizes in some sessions. There was variation in the type and format of activities delivered by providers. Positive patient experiences included engagement, satisfaction with the programme, good within-group relationships and reported behavioural changes. Negative experiences included poor scheduling, large groups, and dissatisfaction with the venue. Where more interactive and visual activities were delivered in smaller groups of 10–15 people with good rapport, there were generally more instances of positive patient experiences, and where there were structural issues such as problems with the scheduling of sessions, poor venues and inadequate resources, there tended to be more negative patient experiences.
Addressing issues that we have identified as being linked to negative experiences with the NHS-DPP could increase uptake, reduce patient drop-out and increase the overall effectiveness of the programme. In particular, modifying structural aspects of the NHS-DPP (e.g. reliable session scheduling, reducing group sizes, enough session resources) and increasing interaction appear particularly promising for improving these outcomes.
Type 2 diabetes is an international public health concern, in which global incidence increased to 422 million in 2014 . Diabetes prevention trials in countries including China , Finland , United States , Japan  and India  have found lifestyle programmes to be effective in promoting behavioural change and reducing the incidence of Type 2 diabetes. Following international evidence, NHS England launched the NHS Diabetes Prevention Programme (NHS-DPP) in 2016; a behavioural intervention for adults in England who have elevated blood glucose levels, (i.e. non-diabetic hyperglycaemia), to slow or stop their progression to developing Type 2 diabetes . The NHS-DPP is the largest diabetes prevention programme globally to achieve universal national coverage , thus, evaluations of NHS-DPP delivery are of particular value for the ongoing success of the programme and may inform other countries that are nationally rolling out health initiatives with multiple providers.
The NHS-DPP has been rolled-out in waves, gradually increasing coverage across England. Potential providers were required to propose a programme to meet NHS England specifications , based on evidence for diabetes prevention programmes to date . NHS England stipulated the following features of service delivery: in groups of no more than 15–20 adults with non-diabetic hyperglycaemia, over at least 13 sessions, with the aims to achieve behaviour change to result in improved diet, increased physical activity and weight loss . The programme was aimed at adults over the age of 18 years with an HbA1c of 6.0–6.4% (42–47 mmol/mol) or fasting plasma glucose level (FPG) of 5.5–6.9 mmol/l. Eligible patients were identified in primary care and referred to a local provider delivering the programme. Before enrolment onto the group sessions, patients were required to attend an initial assessment to introduce the programme, confirm their eligibility, and offered different times and locations for a programme in their local area, as well as collecting baseline measures.
During the third wave roll-out in 2018–2019, during which coverage of the NHS-DPP became nationwide, NHS England commissioned four independent provider organisations to deliver versions of the NHS-DPP, required to adhere to the programme specification . A recent evaluation of the third wave of the NHS-DPP assessed the delivery plans (i.e. key intervention features) and behaviour change content planned by each provider, and reported that providers’ plans were generally in accordance with the NHS programme specification . However, it is not currently known whether this planned programme delivery is being implemented in practice. Whether the four providers are delivering the NHS-DPP in line with their intervention plans is termed ‘intervention fidelity’, that is, whether an intervention is delivered as intended . Accurate description of an intervention as actually delivered, rather than as planned, can increase transparency of intervention implementation, and potentially enhance the quality of interventions .
The Donabedian model  describes the quality of healthcare as being informed by its structure, process and outcomes. Structure describes the context in which healthcare was delivered (e.g. venues, equipment), process represents the transactions between patients and providers throughout healthcare delivery and outcomes represent the consequences of healthcare on the patients . In line with the Donabedian model , this paper defines structural features of the NHS-DPP as venues, resources, session scheduling and equipment, process features are defined as the course content, activities and interactions within the group sessions, and the outcomes are considered as the observed patient experience of the NHS-DPP.
The best information currently available on NHS-DPP delivery is from an evaluation of the pilot NHS-DPP; a smaller-scale NHS-DPP intervention in 2015, before the programme began phased roll-out in 2016 [15, 16]. This evaluation  is currently the only study to report on patient experience of the programme which used qualitative telephone interviews, but the description is brief alongside data from other stakeholders such as commissioners. Nonetheless, key themes relating specifically to patient experience reported patients to benefit from the group support of sessions and positive behavioural changes made . In the 2016 evaluation, providers spoke about tailoring the programme to local context [15, 16]. However, there is yet to be an evaluation of how this adaptation impacts on actual delivery of the NHS-DPP and whether the NHS-DPP can deliver comparable benefits to published trials in reducing the onset of Type 2 diabetes. Crucially, we do not know what structural and process features in the NHS-DPP are driving patient experience. Where multiple providers are delivering a complex multi-site programme, fidelity is likely to be lower , so it is important to understand variation in delivery between providers and sites.
Qualitative interview studies have the strength of eliciting in-depth views of participants, but tend to be sampled from few geographical sites and only include a willing sample of patients from each site. Gaining information on a broader sample of patients’ experiences of the NHS-DPP, based on observation rather than self-report, could provide valuable insight into the success of the programme. This could be of particular value for evaluating the first large-scale national multi-site diabetes prevention programme, as observations would capture the structure and processes of the intervention , which may be useful for the future success of the NHS-DPP and other large-scale public health initiatives going forward.
The main objectives were to: 1) describe the delivery of the NHS-DPP by the four providers, including discrepancies between what was planned and what was delivered and any variation in delivery between providers and sites and 2) describe patient experience of the NHS-DPP, as observed by researchers in the field. A secondary aim was to: 3) compare service delivery with observed patient experience.
Design and sampling
This study was part of a wider national evaluation of the NHS-DPP, described elsewhere . We observed the delivery of the complete NHS-DPP course at eight sites across England between August 2018 and November 2019. Observing whole courses allowed researchers to understand the continuity of delivery across each programme. We observed complete courses at two sites per provider, with one site observed by EC and the other observed by REH. Sites were purposively sampled based on an overall sampling frame of NHS-DPP providers and sites in place during the evaluation period (2018–2019), with the aim of obtaining maximum variation in patient socioeconomic status (SES), ethnicity and geographical location with regards to urban and rural locations.
Participants and consent procedures
The wider programme of research of which this study is a part of was approved by the North West Greater Manchester East NHS Research Ethics Committee (Reference: 17/NW/0426, 1st August 2017). Informed consent was obtained from all participants (patients, accompanying persons and facilitators) on the first day that researchers observed the NHS-DPP session, prior to the session starting and prior to researchers turning on the audio-recorder. It was explained that researchers were audio-recording and taking notes on the content of the sessions. Both the facilitators and patients were assured that their participation would remain confidential.
At four of the eight sites, group cohorts were merged during the second half of the NHS-DPP programme to accommodate for participant drop-out. Consequently, researchers consented a number of new participants at some of the sites. Before the beginning of each group observation, researchers checked that each participant had provided consent to taking part in the research. If there was a participant present who had not met the researcher, full written consent was obtained prior to audio-recording the session. If these new participants did not consent to taking part in the study, the group session was not audio-recorded and researchers attended a corresponding session at another location within the same site (e.g. if a new participant did not wish to consent during group session 11, researchers would attend another session 11 with a different cohort within the same geographical area for that provider to obtain data for that session). Different group cohorts were labelled ‘Group A,’ ‘Group B,’ etc.
Observational data consisted of:
Audio-recorded NHS-DPP sessions (n = 118), including seven initial assessments and 111 group sessions;
Field notes using the Template for Intervention Description and Replication (TIDieR) structured framework , capturing service delivery information at each session. (See Additional file 1 for author-developed data collection form);
Additional 1–2 pages of contemporaneous observational notes per NHS-DPP session. These captured views spontaneously expressed by participants, non-verbal aspects of delivery and any other notable observations.
Researchers attended all group sessions for each site, but were unable to attend an initial assessment consultation for one site with Provider A due to this provider ceasing to deliver face-to-face initial assessments during the data collection period. On four occasions where researchers EC or REH were unable to attend a session, another researcher from the wider team attended on their behalf. Consequently, less detailed observational notes were taken during these sessions, though researchers did discuss their observations with EC and REH following the session and notes were documented based on these discussions.
Service parameters from the TIDieR framework  (e.g. location, deliverer, group size, dose and scheduling, activities, materials, tailoring and fidelity) were extracted by REH from the audio-recordings and field notes and summarised for each site. This framework has previously been used to evaluate the NHS-DPP pilot sites providing telephone support in 2015, which described TIDieR as a useful tool for reporting interventions in applied healthcare research .
All field notes on observed patient experience for each session attended were compiled. Within each set of field notes experiences relating to course content, general engagement, venues, course access, other patients, facilitators and general feedback from patients were read thoroughly and extracted. Instances within the extracted pieces of text were given a label to succinctly capture the documented observation (example labels of instances: “good rapport built with facilitator”; “group support”). The labels of instances were grouped into categories to represent common positive and negative experiences observed by researchers (example category: “good group relationships between facilitators and peers”). The number of instances for each category were documented for each provider (e.g. “17 instances of category X observed with Provider Y across 26 sessions”). See Additional files 2 and 3 for the extracted data.
We made the decision to analyse the number of observed instances of patient experience throughout the courses, rather than analysing the number of sessions which included instances. Sometimes there was more than one instance of a category within a session which were unrelated (e.g. if patients had difficulty in finding the venue, and then later another patient stated that the venue was far away from their home, these were treated as two separate instances regarding the venue, but both occurred within the same session). As this was a content analysis, authors were not trying to quantify the number of sessions in which experiences occurred, rather, patterns in the data were analysed. Authors therefore analysed the number of instances for each category that were identified across provider courses, presented alongside number of observed sessions for each provider to give readers an indication of programme duration.
Each providers’ programme features identified using the TIDieR framework  were compared with the categories of patient experience to identify whether observed patient experiences corresponded to variations in providers’ programme delivery. We provide a qualitative assessment of associations on these links between delivery and experience, as the patient experience data were not suitable for inferential statistics and statistical analyses were not planned.
Description of NHS-DPP delivery
A total of 36 facilitators, 398 patients and 21 family members consented to researchers attending, observing and audio-recording NHS-DPP sessions. Table 1 illustrates demographic characteristics at each site observed. The median Index of Multiple Deprivation (IMD) profile  for the eight sites was two, indicating generally high levels of deprivation, and ethnicity profiles according to site postcode  ranged from 15 to 96% white. Table 2 describes the service delivery features observed at each site.
Results extracted using the TIDieR framework indicated that NHS-DPP delivery was generally in line with what was specified by NHS England in relation to session content, facilitators delivering the programme and the use of community venues for session delivery. Some discrepancies were observed between what providers planned to deliver and what they actually delivered (highlighted in Table 2). For example, in seven observed sessions (6%) providers A, B and C had more patients attending a group session (n > 20) than was stated in their delivery plans (maximum of between 15 and 20 patients). The scheduling of sessions were often discrepant, especially for Provider A, who had up to a three-month gap between their maintenance sessions, which were supposed to be monthly. Due to a supplier issue, Site C1 did not receive a delivery of pedometers until week seven instead of week one, which meant patients were unable to track their steps or report back any progress.
Activities included a mixture of education (e.g. the consequences of Type 2 diabetes, dietary and physical activity recommendations), group support (e.g. barriers and solutions to healthy living), knowledge testing (e.g. quizzes), visual activities (e.g. measuring the amounts of sugar and fats in food), and activities led by patients (e.g. collecting food packaging). The types of activities and their delivery varied across providers. For example, Provider A focused on group discussions and delivered visual activities via the use of posters and food models, Provider B delivered more educational activities, Provider C delivered quizzes to assess patients’ current knowledge about particular topics and Provider D had a focus on patients leading the session (e.g. collecting food packaging). All providers included group discussions in their delivery format, but Providers A and C accompanied these discussions with the use of worksheets and posters, whereas Provider B used PowerPoint and Provider D used external leaflets to accompany the session. Providers B and D signposted to local services at both sites observed.
There was some variation across sites regarding the tailoring and modifications of the programme. Sites A1 and C1 in particular tailored session content to the group demographic. For example, site A1 included discussions about Asian foods and lifestyles and site C1 tailored information for an older age group. Other sites only tailored the intervention in response to group conversations. Sites A1, D1 and D2 handed out a number of additional leaflets to supplement the session content. On occasions where a session had to be cancelled, sites C1, C2 and D2 rescheduled their sessions, whereas site A1 covered the content of two sessions within one session. During one session in site D2 when there was a low turn-out of patients, content was delivered at the following session when more patients were present.
Description of observed patient experience
Field note content analysis yielded 127 instances of positive experiences and 83 instances of negative experiences observed across the 118 sessions attended. From these observed instances, three categories of positive experience and three categories of negative experience were identified. Table 3 highlights some of the key features of each of the provider programmes (identified using the TIDieR framework ), alongside the number of instances of positive and negative patient experiences observed per category across providers. Table 4 provides examples of both ‘positive’ and ‘negative’ instances of patient experiences that were documented in researchers’ field notes. (See Additional files 2 and 3 for all documented positive and negative patient experiences, extracted from observational notes).
Generally, patients demonstrated engagement and satisfaction with the programme (n = 59 instances extracted from observational notes of 118 sessions). Researchers observed engagement with activities and discussions, and patients expressed enjoyment of mindfulness and visual activities in particular. Patients also reported general satisfaction with the NHS-DPP (e.g. telling others about the programme, learning about healthier foods). Good relationships within the groups were observed (n = 51 instances extracted from observational notes of 118 sessions). For example, facilitators built a good rapport with their groups and peer support was noted, such as meeting each other outside of the programme, giving suggestions or advice to each other and sharing honest accounts and experiences. Patients also reported positive behavioural changes made (n = 17 instances extracted from observational notes of 118 sessions), including increasing daily steps, learning new recipes and corresponding weight loss.
However, a number of notable negative experiences were observed and documented by researchers. There were observed structural issues with the scheduling and size of group sessions (n = 41 instances extracted from observational notes of 118 sessions), some of which included incorrect session dates and times provided, oversubscribed sessions, problems with text reminders, future session dates not confirmed and cancelled sessions not communicated. There were observed factors influencing disengagement or dissatisfaction within the session (n = 27 instances extracted from observational notes of 118 sessions), including patients disengaging with activities (e.g. too much complex information, difficult activities, room layout), issues with the session resources (e.g. unable to provide resources, issues with pedometers) and general patient dissatisfaction or feedback from the session. For example, one patient reported that they would have liked more demonstrations and practical sessions on cooking healthy meals. There were structural issues reported with some of the site venues (n = 15 instances extracted from observational notes of 118 sessions), such as the rooms being too hot in temperature, patients having difficulty finding the room or venue, access issues, distance of venue from patients’ homes and noise disruption.
Relationships between patient experience and provider delivery
Providers A and C had more instances of positive patient experience regarding engagement and satisfaction with the programme and more observed positive relationships within their sessions documented in researcher field notes. (See Table 3 for numbers of instances observed and the number of sessions observed across each provider). Assessment of the key features in their programmes show that these providers had group sizes of generally between 10 and 15 people and delivered more interactive and visual activities with the use of worksheets, posters and food models. Provider D which delivered more patient-led activities (e.g. collecting food packaging) had more instances of observed behavioural changes in comparison to the other providers.
Regarding observed negative patient experiences, Providers A and C had more instances of reported issues with the scheduling of sessions compared to Providers B and D. These included being unable to confirm future session dates and incorrect session dates and times provided. A higher number of instances influencing dissatisfaction and disengagement within sessions was observed for Providers B and C. For example, such instances were documented when patients reported complex information difficult to understand, issues with session resources (e.g. not enough handbooks) and group sizes > 15 people. Provider C had more reported issues with the venue compared to other providers.
Our observations suggest that NHS-DPP delivery was generally in line with the NHS service specification  with regards to the session content and processes of the NHS-DPP, according to the data extracted using the TIDieR framework . Researcher field notes indicated positive patient experiences, as well as negative patient experiences in relation to the structure of the NHS-DPP. There are significant organisational differences and modes of delivery which appear to have generated both positive and negative responses from patients of the NHS-DPP. In particular, there appeared to be more positive patient experiences observed within sessions (e.g. group rapport, engagement with interactive activities) and more negative patient experiences appeared to be linked to structural issues (e.g. session scheduling, group sizes, the venue, and issues with resources). More instances of positive patient experiences were observed when provider programmes had more visual and interactive activities, delivered in groups of 10–15 people. Thus, there are some improvements which, if addressed by providers, may improve the overall running of the programme.
Strengths and limitations
To our knowledge, this is the first paper describing NHS-DPP delivery, including structural features, within-session process features and observed patient experience. We were able to observe the whole NHS-DPP course at each of the eight sites and observed a wide range of facilitators with varying experience and backgrounds. All sessions were audio-recorded, a ‘gold standard’ for fidelity evaluations , enabling a more detailed data extraction of the programme delivery. The use of the TIDieR framework  allowed for the complexities of delivering such an intervention in practice to be transparently documented.
This paper has provided a novel way of assessing patient experience, utilising in-depth observational notes across a much larger sample than would have been possible with qualitative research. Thorough observational notes were written (up to two sides of A4) per session. However, the patient experience described in this paper was that observed by researchers and documented in their notes, thus, observed patient experience was researchers’ interpretation. Only the corresponding field notes for each session were analysed to assess observed patient experience, as the audio recordings further presented over 200 hours of data. However, researchers’ observational notes were able to capture occurrences within sessions and non-verbal aspects of delivery which would not have otherwise been captured on the audio recording (e.g. informal conversations with patients, group interactions during activities). The use of researcher field notes are not often used to analyse or present data, however, we have found this a useful method to provide an in-depth analysis of what happened within sessions, especially with regards to the structural issues observed. These are valuable insights into the running of a national programme and may contribute to its future success in ensuring that the intervention continues.
Researchers were only able to observe and document volunteered views in their field notes, thus the data presented is naturally occurring data. For example, if a particular observation was not documented in researchers’ field notes for that session (such as high engagement), it does not mean it did not happen in that session. Further, researchers could only observe and interact with patients who continued attendance at the NHS-DPP. Consequently, this study cannot provide insights into barriers of attendance; a limitation also present in previous research on patient experience of the NHS-DPP . Despite not having any formal estimation of observation reliability, researchers discussed what should be included in the observational notes beforehand, and both researchers documented similar types of observations in their notes (see Additional files 2 and 3). Further, despite having single observers at the sessions, both researchers each attended the delivery of a whole programme for each of the four providers delivering the NHS-DPP.
Although we attended the full NHS-DPP course at eight sites across England, the sample of eight geographical sites is still small, yet all that was feasible, given the length of the NHS-DPP programme (9–12 months), and the resources required for intensive observation. Further, we cannot be sure from these observations whether the issues identified are related to the particular courses we observed, or systemic issues that reflect the way NHS-DPP providers organise and run their courses. However, we have been able to identify associations between providers’ programme characteristics and observed patient experience at the eight sites attended.
Despite this, our purposive sample sought to assess diversity in NHS-DPP settings; researchers aimed to sample sites with as much variation in SES, ethnicity and geographical location as possible and 455 participants were consented. This approach has additional advantages to qualitative research examining patient experience, which gathers in-depth views from a smaller number of participants, usually somewhat restricted by geographical site. Our study includes observational data rather than self-report, thus does not have the same reporting biases. Although, it could be argued that the observed patient experience is not as direct as gathering views on patient experience in interviews. Nonetheless, this study provides a description into the patient experiences observed in the NHS-DPP, in which the analysis has the advantage of identifying broad patterns in the data.
Relation to existing research
The only previous research to explore patients’ experiences of the NHS-DPP was during the pilot phase . However, this interview study was conducted before the NHS-DPP was implemented nationally, patient data were analysed alongside data from other NHS-DPP stakeholders, and the comparison of patient experiences across sites and providers was not within the previous evaluation’s scope. Nonetheless, our observations are in accordance with those findings, as positive relationships were observed within groups, both with other peers and facilitators, and patients reported positive behavioural changes made to their lifestyles. The current study has further highlighted two new findings relating to the delivery of the NHS-DPP; the use of interactive and visual activities within NHS-DPP sessions (process features) appear to enhance patient experience, but issues with structural features of the programme such as session scheduling, group size and issues with session resources appear to impact negatively on patient experience.
Whilst previous qualitative studies on patient experiences of other behavioural interventions have provided an in-depth insight into interpersonal factors and participant motivations [23,24,25], they have not fully addressed the structural factors which are also important for the successful implementation of an intervention. Although the qualitative literature did allude to the fact that having the programme sites in more accessible locations with greater flexibility in session times and days could further improve patient experience [23,24,25], this has not been extensively researched. However, such structural features can have a direct influence on the processes and outcomes in programmes, for example, if there is insufficient resources and equipment or sessions cannot be scheduled, this can prohibit patients from accessing the support they require from the programme . As found in the present study, the scheduling of sessions, group sizes, issues with provider resources and site venues were all structural issues which appeared to negatively affect patient experience. Recent data published on the early outcomes of the NHS-DPP highlight that course completion differed between providers ; upon comparing our data with this early outcome data, it appears that the providers with the lowest course completion rates  had more scheduling issues observed in the current study.
Implications for practice
We observed disengagement within the sessions when patients reported information was difficult to understand, when there were issues with obtaining session resources, and when group sizes were greater than 15 people. Although we cannot be certain whether these are systemic issues in the way NHS-DPP providers are delivering their courses, our findings suggest that delivering more interactive activities with less complex information and having enough resources to supplement the session content may enhance patient experience. Given the NHS-DPP is the first national roll-out of a diabetes prevention programme to ever be implemented in routine practice, our findings may be of great value to make improvements to future waves of the programme, or for commissioners of other public health initiatives.
Despite the NHS-DPP being a national programme, there is variation in how the intervention is delivered by providers. There are clearly some deviations from providers’ protocols and what was specified by NHS England , but we do not know whether this variation is also present in other behavioural programmes. The importance of tailoring the intervention content according to the group demographics if often argued, known as adaptation in form (e.g. variation within providers according to local context) [17, 27]. However, other types of variation between providers (e.g. group sizes) may be explained by pressures faced by providers such as waiting lists to get onto the course, people wanting to switch courses, local insights of ‘did-not-attend’ rates, or incentives for commercial providers to enrol patients onto the NHS-DPP. Such variation is not adaptation, but suggests drift from the original NHS Service Specification , especially at the structural level with regards to the scheduling of sessions and group sizes. Too much drift from the specification will result in the NHS-DPP not being delivered with fidelity to the evidence base, and it is unclear how that would impact on effectiveness. Such structural issues observed highlight the wider issues of rolling out a national programme. The NHS-DPP started with seven small pilot sites in 2015 and rolled out to a multi-site programme in 2016, with commercial providers under pressure to deliver results with limited capacity across large geographical areas.
Implications for research
Now the NHS-DPP is in the fourth year of implementation, some of these structural issues may have since been improved, although this is not certain. There is now a fifth provider commissioned to deliver the NHS-DPP alongside the other four providers; further observations of the NHS-DPP in the field would be beneficial to establish whether these structural features (e.g. session scheduling) remain an issue, or whether such issues are only present in the early stages of programme implementation. Further, it would be useful to replicate and advance this method using two researchers at each site observation and formal reliability testing, which would provide wider applicability of the current model used.
Future research could also examine the impact that different facilitator characteristics may have on the outcomes of the NHS-DPP. We observed 36 facilitators from diverse backgrounds with varying levels of experience and facilitating styles. Our observations suggested that good relationships with facilitators were linked with positive patient experience, but it is not clear which features of facilitators or training best brings this about. Further, we do not know the impact of the therapeutic relationship between the facilitator and the group on learning and retention of the NHS-DPP. Qualitative interviews with facilitators about their views and experiences of delivering different aspects of the NHS-DPP would give insight into additional requirements for facilitators going forward. Lastly, the authors of the present study have also assessed fidelity of delivery of behaviour change techniques in the NHS-DPP which is described in a separate publication .
Overall, we observed positive instances of patient experience such as engaging with the overall programme, providing peer support, developing good relationships with facilitators and making positive behavioural changes. Such experiences were observed more often in programmes containing interactive and visual activities, delivered in groups of 10–15 people in line with the programme specification. Our observations of negative patient experience, in particular concerning the scheduling and size of group sessions, are improvements at the structural level that may further improve the delivery of the NHS-DPP and its longer-term success. By addressing these issues we have identified as being linked to negative patient experience, this could increase the uptake, reduce drop-out and increase overall effectiveness of the NHS-DPP.
Availability of data and materials
All observational notes on patient experience analysed during this study are included in this published article and/or supplementary information files. The service delivery dataset generated and/or analysed during the current study are not publicly available due to confidentiality agreements with the provider organisations, as some information is commercially sensitive. Some datasets are available from the corresponding author on reasonable request, although authors will require the explicit permission of the relevant provider organisations.
National Health Service Diabetes Prevention Programme
Template for Intervention Description and Replication framework
World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2016.
Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, Zhang B, Feng X, Li H, Chen X, Cheng YJ. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing diabetes prevention outcome study. Lancet Diabetes Endocrinol. 2019;7(6):452–61.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract. 2005;67(2):152–62.
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian diabetes prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–97.
NHS England. NHS diabetes prevention Programme (NHS DPP). 2017; Available from: https://www.england.nhs.uk/diabetes/diabetes-prevention/2017/ (Accessed 29 November 2019).
Valabhji J, Barron E, Bradley D, Bakhai C, Fagg J, O’Neill S, Young B, Wareham N, Khunti K, Jebb S, Smith J. Early outcomes from the English National Health Service Diabetes Prevention Programme. Diabetes Care. 2020;43(1):152–60.
England NHS. Service Specification No. 1: Provision of behavioural interventions for people with non-diabetic hyperglycaemia. [Version 01]; 2016.
Ashra NB, Spong R, Carter P, Davies MJ, Dunkley A, Gillies C. A systematic review and meta-analysis assessing the effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes mellitus in routine practice. London: Public Health England; 2015. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/456147/PHE_Evidence_Review_of_diabetes_prevention_programmes-_FINAL.pdf (Accessed 29 November 2019).
Hawkes RE, Cameron E, Bower PB, French DP. Does the design of the NHS diabetes prevention Programme intervention have fidelity to the programme specification? A document analysis. Diabet Med. 2020;37(8):1357–66.
Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, Ogedegbe G, Orwig D, Ernst D, Czajkowski S. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH behavior change consortium. Health Psychol. 2004;23(5):443–51.
Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, Altman DG, Barbour V, Macdonald H, Johnston M, Lamb SE. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.
Donabedian A. The quality of care: how can it be assessed? JAMA. 1988;260(12):1743–8.
Penn L, Rodrigues A, Haste A, Marques MM, Budig K, Sainsbury K, Bell R, Araújo-Soares V, White M, Summerbell C, Goyder E. NHS diabetes prevention Programme in England: formative evaluation of the programme in early phase implementation. BMJ Open. 2018;8(2):e019467.
Rodrigues AM, Haste A, Penn L, Bell R, Summerbell C, White M, Adamson AJ, Sniehotta FF. Stakeholders’ perceptions and experiences of the National Health Service diabetes prevention programme in England: qualitative study with service users, intervention providers and deliverers, commissioners and referrers. BMC Health Serv Res. 2020;20(1):1–3.
Hawe P, Shiell A, Riley T. Complex interventions: how “out of control” can a randomised controlled trial be? BMJ. 2004;328(7455):1561–3.
Sutton M. Evaluating the NHS Diabetes Prevention Programme (NHS DPP): the DIPLOMA research programme (Diabetes Prevention Long term Multimethod Assessment). Health Services and Delivery Research programme, project. 2017; Available from: https://www.journalslibrary.nihr.ac.uk/programmes/hsdr/164807/#/ (Accessed 27 April 2020).
Cotterill S, Knowles S, Martindale AM, Elvey R, Howard S, Coupe N, Wilson P, Spence M. Getting messier with TIDieR: embracing context and complexity in intervention reporting. BMC Med Res Methodol. 2018;18(1):12.
Department for Communities and Local Government. The English indices of deprivation. 2015; Available from: https://www.gov.uk/government/statistics/english-indices-of-deprivation-2015 (Accessed 30 January 2020).
Office for National Statistics, taken from Census. 2011; Available from: https://www.nomisweb.co.uk/census/2011/ks201ew (Accessed 30 January 2020).
Borrelli B. The assessment, monitoring, and enhancement of treatment fidelity in public health clinical trials. J Public Health Dent. 2011;71(s1):S52–63.
Klein J, Brauer P, Royall D, Israeloff-Smith M, Klein D, Tremblay A, Dhaliwal R, Rheaume C, Mutch DM, Jeejeebhoy K. Patient experiences of a lifestyle program for metabolic syndrome offered in family medicine clinics: a mixed methods study. BMC Fam Pract. 2018;19(1):148.
Clark AM, King-Shier KM, Spaling MA, Duncan AS, Stone JA, Jaglal SB, Thompson DR, Angus JE. Factors influencing participation in cardiac rehabilitation programmes after referral and initial attendance: qualitative systematic review and meta-synthesis. Clin Rehabil. 2013;27(10):948–59.
Casey D, De Civita M, Dasgupta K. Understanding physical activity facilitators and barriers during and following a supervised exercise programme in type 2 diabetes: a qualitative study. Diabet Med. 2010;27(1):79–84.
Campbell SM, Roland MO, Buetow SA. Defining quality of care. Soc Sci Med. 2000;51(11):1611–25.
Medical Research Council. Developing and evaluating complex interventions. 2019; Available from: https://mrc.ukri.org/documents/pdf/complex-interventions-guidance/ (Accessed 30 January 2020).
French DP, Hawkes RE, Bower P, Cameron E. Is the NHS diabetes prevention Programme intervention delivered as planned? An observational study of intervention delivery. Ann Behav Med. 2020; (in press).
We would like to thank the NHS-DPP providers for assisting in the organisation of observations at each site. We are grateful to all the facilitators and attendees who consented to observations of NHS-DPP sessions. With thanks to researchers Hannah Long and Kelly Howells who both attended the NHS-DPP sessions for data collection when researchers EC or REH were unable to attend. We would also like to thank the following researchers in the DIPLOMA team who provided valuable feedback during the manuscript preparation: Emma Mcmanus, William Whittaker, Rathi Ranvindrarajah, Lisa Miles, Matthew Sutton, Paul Wilson, David Reeves and Simon Heller.
This work is independent research funded by the National Institute for Health Research (Health Services and Delivery Research, 16/48/07 – Evaluating the NHS Diabetes Prevention Programme (NHS DPP): the DIPLOMA research programme (Diabetes Prevention – Long Term Multimethod Assessment)). The views and opinions expressed in this manuscript are those of the authors and do not necessarily reflect those of the National Institute for Health Research or the Department of Health and Social Care.
Ethics approval and consent to participate
The wider programme of research of which this study is a part of was reviewed and approved by the North West Greater Manchester East NHS Research Ethics Committee (Reference: 17/NW/0426, 1st August 2017). Full written consent was obtained from all participants included in this study.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hawkes, R.E., Cameron, E., Cotterill, S. et al. The NHS Diabetes Prevention Programme: an observational study of service delivery and patient experience. BMC Health Serv Res 20, 1098 (2020). https://doi.org/10.1186/s12913-020-05951-7